drugset / Trial / NCT01575301
DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R Agonists
Completed
411 enrolled
University of Dundee
Newcastle-upon-Tyne Hospitals NHS Trust · collabOxford University Hospitals NHS Trust · collabRoyal Devon and Exeter NHS Foundation Trust · collab
NaSingle-groupOpen-labelBasic science
Summary
The purpose of this study is to collect a cohort of patients treated with GLP-1R Agonists and to assess phenotypic, genetic and genomic biomarkers of glycaemic response to these agents.
Timeline
- Start
- 2011-03
- Primary completion
- 2015-07
- Completion
- 2015-12-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Exenatide | Peptide | — | — |
| Subject | Liraglutide | Peptide | — | — |